Enhancing Prospective Thinking in Early Recovery (HOME)
- Conditions
- Alcohol Use Disorder
- Interventions
- Device: Virtual Reality
- Registration Number
- NCT06302413
- Lead Sponsor
- Indiana University
- Brief Summary
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question\[s\] this trial aims to answer are:
Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Abstinence between ≥14 days and ≤1 year
- Verbal endorsement of commitment to recovery
- Outpatient
- Psychotropic drugs for SUD-comorbidity
- Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
- English comprehension
- Unstable medical disorders
- Habitual drug use
- Mu-opioid drugs
- Smell/taste disorders
- Unstable psychiatric conditions
- Extravagant/elaborate face tattoos
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Virtual Reality Virtual Reality Participants in this arm will receive the following interventions: Virtual Reality Park Virtual Reality Avatar Treatment As Usual Virtual Reality Participants in this arm will receive the following interventions: Virtual Reality Park
- Primary Outcome Measures
Name Time Method Increased Length of Abstinence Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. The Virtual Reality Avatar experience will increase the length of abstinence periods.
Future Time Perspective with the Delayed Discounting Behavioral Task and Future Self Continuity Questionnaire Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. The Virtual Reality Avatar experience will increase future time perspective.
Reduced Use of Drug Using Days Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit The Virtual Reality Avatar experience will reduce drug using days.
Increased (overall) Abstinence Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. The Virtual Reality Avatar experience will increase abstinence.
Delayed Reward Preference with the Delayed Discounting Behavioral Task Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. The Virtual Reality Avatar experience will increase preference for delayed rewards.
Future Self-identification with Future Self Continuity Questionnaire Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit The Virtual Reality Avatar experience will increase future self-identification.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Indiana University School of Medicine - Goodman Hal
🇺🇸Indianapolis, Indiana, United States